Mucosal irritation, adaptive cytoprotection, and adaptation to topical ammonia in the rat stomach.
BACKGROUND
The urease-ammonia (NH4OH) system has been proposed to play a major role in the pathogenesis of the Helicobacter pylori-associated gastritis, but the mechanism of the mucosal damage has not been fully explained. This study was designed to examine possible adaptive cytoprotection and the adaptation of rat gastric mucosa to the irritant action of NH4OH and urease.


RESULTS
Single application of NH4OH alone in various concentrations (15-500 mM) caused concentration-dependent mucosal damage starting with 30 mM and reaching a maximum at 250 mM NH4OH, similar to that obtained with 100% ethanol; it was accompanied by a decrease in gastric blood flow (GBF) to approximately 30% of the normal value. When the mucosa was first exposed to the low, non-damaging concentration (15 mM) of NH4OH and then insulted with 100% ethanol, the extent of ethanol damage was greatly attenuated as compared with that caused by ethanol alone. This adaptive cytoprotection was accompanied by the rise in GBF and reversed, in part, by the pretreatment with indomethacin, an inhibitor of prostaglandin (PG)-cyclooxygenase; with L-NAME, a blocker of NO-synthase; or with capsaicin deactivating the sensory nerves. Damaging concentrations of NH4OH (125 mM) caused widespread mucosal damage after the first application, but with repeated insults with 125 mM NH4OH a gradual reduction in the mucosal lesions, accompanied by enhanced mucosal cell proliferation and over-expression of epidermal growth factor (EGF) (using immunocytochemistry) and mRNA of EGF (using trans-reverse polymerase chain reaction), were observed.


CONCLUSIONS
NH4OH alone damages gastric mucosa only at the concentration exceeding that found in H. pylori-infected stomachs, whereas at lower concentrations it acts as 'mild' irritant to induce adaptive cytoprotection. This adaptive cytoprotection appears to be mediated, in part, by endogenous PG, sensory nerves, and an arginine-NO-dependent pathway, and repeated applications of NH4OH induce gastric adaptation, probably mediated by enhanced expression of EGF and its receptors and by an increased cell proliferation.
Brzozowski
T
T
Institute of Physiology, Jagiellonian University School of Medicine, Cracow, Poland.
Konturek
P C
PC
Konturek
S J
SJ
Ernst
H
H
Sliwowski
K
K
Hahn
E G
EG
D000222:Adaptation, Physiological; D000287:Administration, Topical; D000641:Ammonia / Q000008:administration & dosage* / Q000494:pharmacology*; D000818:Animals; D002211:Capsaicin / Q000494:pharmacology; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D004815:Epidermal Growth Factor / Q000032:analysis; D000431:Ethanol / Q000633:toxicity; D005260:Female; D005753:Gastric Mucosa / Q000187:drug effects; D005755:Gastrins / Q000097:blood; D006635:Histamine H2 Antagonists / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D007509:Irritants / Q000008:administration & dosage* / Q000494:pharmacology*; D008297:Male; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D009475:Neurons, Afferent / Q000187:drug effects; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D011453:Prostaglandins / Q000502:physiology; D011899:Ranitidine / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D011970:Receptors, Histamine H2 / Q000187:drug effects; D013270:Stomach / Q000098:blood supply / Q000187:drug effects*; D016211:Transforming Growth Factor alpha / Q000032:analysis; D014510:Urease / Q000494:pharmacology
D016861:Cyclooxygenase Inhibitors; D005755:Gastrins; D006635:Histamine H2 Antagonists; D007509:Irritants; D011453:Prostaglandins; D011970:Receptors, Histamine H2; D016211:Transforming Growth Factor alpha; D000431:Ethanol; D004815:Epidermal Growth Factor; D000641:Ammonia; D011899:Ranitidine; D019001:Nitric Oxide Synthase; D014510:Urease; D002211:Capsaicin; D019331:NG-Nitroarginine Methyl Ester; D007213:Indomethacin